The Chicagoland-based companies team up to offer on-demand delivery of thousands of everyday essentials CHICAGO and DEERFIELD, Ill., Feb. 20, 2025 /PRNewswire/ -- Grubhub announced today that it has teamed up with Walgreens to bring Walgreens and Duane Reade locations nationwide to its marketplace. Through this collaboration, customers have access to 15,000 items for on-demand delivery — including beauty, health and wellness, snacks, personal care, household items, toys, and more.Grubhub is enhancing the cu ...

DOVER, Del., Feb. 20, 2025 /PRNewswire/ -- Chesapeake Utilities Corporation (NYSE:CPK) has been recognized as a 2025 Warrior Friendly Business by the Delaware State Chamber of Commerce Joint Military Affairs Committee (JMAC). The Company was honored in the Over 50 Employees category. The award, which recognizes the efforts of employers to support service members, veterans and their family members through workplace initiatives, was presented on Feb. 20 at the JMAC's annual State of the Guard Address.Chesapea ...

San Diego, California--(Newsfile Corp. - February 20, 2025) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company") a clinical-stage biotechnology company developing disulfides that drive the production of critically important intracellular antioxidants and other therapeutic compounds, today announced that it has entered into a consulting and investor relations agreement effective February 15, 2025 (the "Agreement") with Bull Markets Media GmbH (the "Consultant"), a Ge ...

Altria's (NYSE: MO ) stock delivered a zero total return to investors since early November 2024 when I shared my previous bullish thesis . The stock lagged behind the broader U.S. equity market, but thisI am a highly experienced Chief Financial Officer (CFO) with a strong background in the oilfield and real estate industries. With over a decade of experience in finance, I have led numerous complex due diligence efforts and M&A transactions, both domestically and internationally.In recent years, I have devel ...

Innovative Faculty Research Grants and 19 Applied Learning Projects with 50 Students Help Drive the University's Global Digital Journey CHARLES TOWN, W. Va., Feb. 20, 2025 /PRNewswire/ -- American Public University System (APUS) proudly celebrates significant academic research advancements, showcasing groundbreaking projects and impactful global collaborations in 2024. APUS faculty have secured grants for 19 recent projects (12 domestic and seven international projects across three continents) with multidis ...

NEW YORK, Feb. 20, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Kristen Scholer delivers the pre-market update on February 20th NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 20TH + WALMART REPORTS EARNINGS Walmart shares near all-time highs following earnings report President Trump floats idea of tariffs on auto, ch ...

I initiated a buy rating on Graham Corporation (NYSE: GHM ) last month and since then, the stock has underperformed the S&P 500 index by falling ~9% as compared to the S&P 500 increasing ~6% at the same time. Although the stock wasI am a value focused investor, conducting fundamental research on sectors like but not limited to chemicals, homebuilders, building materials, industrials and metals & mining. I prefer to invest in stocks which are cheaply available and have a catalyst in the near future. My inves ...

公司情况 - 阿拉莫斯黄金公司是一家优质黄金矿业公司，大部分产量来自加拿大，在墨西哥穆拉托斯地区也有部分产量，未来几年产量将增长 [1] - 投资组合过去6年的复合年增长率为26% [2] 投资策略 - 主要投资自然资源行业的困境反转公司，典型持有期为2 - 3年，注重价值投资可提供下行保护并获得上行收益 [2]

文章核心观点 - 礼来公司凭借GLP - 1药物获得资金，欲在心脏病、听力损失等领域进行重大投资，还在测试药物Kisunla预防阿尔茨海默病，若成功将是治疗该疾病的重大变革 [1][3][5] 公司现状 - 礼来的替尔泊肽（Mounjaro用于糖尿病，Zepbound用于肥胖）改变了公司，自2022年Mounjaro获批后公司销售额增长近60% [2] - 过去三年礼来股价飙升268%，市值达8230亿美元，为医疗保健公司中最高 [2] 公司规划 - 公司希望将现有成功拓展到其他疾病领域 [3] 阿尔茨海默病药物研究 - 公司正在测试药物Kisunla预防阿尔茨海默病，该药物是一种单克隆抗体，可清除大脑中与该疾病相关的淀粉样斑块，目前已获批用于治疗早期患者 [3] - 公司在教堂、沃尔玛停车场等地招募老年人进行血液检测，以确定其患病风险，部分试验参与者将接受Kisunla，部分接受安慰剂，待足够参与者被诊断患病后，公司将对比两组差异 [4] - 若能使一半患者预防该疾病，将是阿尔茨海默病诊断和治疗的革命，可能标志此类药物使用的重大转折点 [5]

文章核心观点 - 礼来公司首席科学官丹·斯科夫朗斯基致力于研发优质肥胖症药物，行业竞争不仅关注减肥效果 [1][2] 公司动态 - 礼来公司首席科学官丹·斯科夫朗斯基已凭借周注射剂Zepbound取得成功，正尝试研发更便捷的每日口服药及更强效注射剂，还有九种肥胖症药物处于临床试验阶段 [1] 行业竞争 - 创造下一款伟大药物的竞争不再仅关乎减肥效果，投资者和分析师开始有此观点 [2] - 安进公司实验药物MariTide在2期研究中使患者体重最多减轻20%，但结果公布当日安进股价下跌约5%，因投资者担忧其无法与礼来的Zepbound和诺和诺德的Wegovy竞争，后两者有多年先发优势 [2]